{"product_id":"retatrutide-20-mg","title":"Retatrutide 20 mg","description":"\u003cstyle\u003e\n.cert-wrap{\n  margin:28px 0;\n  text-align:center;\n}\n\n.cert-btn{\n  display:inline-flex;\n  align-items:center;\n  justify-content:center;\n  gap:9px;\n  padding:14px 24px;\n  background:#005CFF;\n  color:#fff !important;\n  text-decoration:none !important;\n  border-radius:10px;\n  font-size:14px;\n  font-weight:700;\n  letter-spacing:.3px;\n  transition:.2s ease;\n}\n\n.cert-btn:hover{\n  opacity:.9;\n  transform:translateY(-1px);\n}\n\n.cert-btn-icon{\n  font-size:17px;\n}\n\n.cert-image{\n  display:block;\n  width:100%;\n  max-width:900px;\n  height:auto;\n  margin:0 auto;\n  border-radius:12px;\n  background:#fff;\n}\n\u003c\/style\u003e\n\n\u003cdiv class=\"cert-wrap\"\u003e\n\n  \u003ca class=\"cert-btn\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0701\/0421\/9715\/files\/WhatsApp_Image_2026-09-23_at_01.56.48.jpg?v=1790208418\" target=\"_blank\" rel=\"noopener noreferrer\"\u003e\n    \u003cspan class=\"cert-btn-icon\"\u003e☑️\u003c\/span\u003e\n    POGLEDAJ CERTIFIKAT\n  \u003c\/a\u003e\n\n\u003c\/div\u003e\n\n\u003cdiv style=\"font-family: Inter,Arial,sans-serif; background: #121212; color: #ffffff; max-width: 1100px; margin: 0 auto; border-radius: 24px; overflow: hidden; box-sizing: border-box;\"\u003e\n\u003c!-- HERO --\u003e\n\u003cdiv style=\"padding: 60px 22px 48px; background: linear-gradient(135deg,#121212 0%,#121212 60%,#005CFF 180%); box-sizing: border-box;\"\u003e\n\u003cdiv style=\"display: inline-flex; align-items: center; gap: 8px; border: 1px solid #005CFF; background: #121212; padding: 8px 12px; border-radius: 50px; font-size: 9px; letter-spacing: 1.5px; color: #ffffff; text-transform: uppercase; margin-bottom: 22px;\"\u003e\n\u003cspan style=\"width: 6px; height: 6px; background: #005CFF; border-radius: 50%; display: inline-block;\"\u003e\u003c\/span\u003e ISTRAŽIVAČKA SERIJA \/ 01\u003c\/div\u003e\n\u003cdiv style=\"font-size: 10px; letter-spacing: 2.5px; color: #f3f3f3; text-transform: uppercase; margin-bottom: 12px;\"\u003eRETATRUTIDE · LY3437943\u003c\/div\u003e\n\u003ch1 style=\"font-size: clamp(54px,17vw,100px); line-height: .86; letter-spacing: -4px; margin: 0; font-weight: 800; color: #ffffff;\"\u003eRETA\u003cbr\u003e\u003cspan style=\"color: #005cff;\"\u003e20 MG\u003c\/span\u003e\n\u003c\/h1\u003e\n\u003cp style=\"max-width: 620px; color: #f3f3f3; font-size: 14px; line-height: 1.75; margin: 25px 0 0;\"\u003eRetatrutide je eksperimentalna molekula koja se istražuje kao trostruki agonist GIP, GLP-1 i glukagonskih receptora.\u003c\/p\u003e\n\u003cdiv style=\"display: flex; flex-wrap: wrap; gap: 7px; margin-top: 22px;\"\u003e\n\u003cspan style=\"border: 1px solid #FFFFFF; padding: 8px 11px; border-radius: 50px; font-size: 9px; color: #ffffff;\"\u003eGIP\u003c\/span\u003e \u003cspan style=\"border: 1px solid #FFFFFF; padding: 8px 11px; border-radius: 50px; font-size: 9px; color: #ffffff;\"\u003eGLP-1\u003c\/span\u003e \u003cspan style=\"border: 1px solid #FFFFFF; padding: 8px 11px; border-radius: 50px; font-size: 9px; color: #ffffff;\"\u003eGLUKAGON\u003c\/span\u003e \u003cspan style=\"background: #005CFF; border: 1px solid #005CFF; padding: 8px 11px; border-radius: 50px; font-size: 9px; color: #ffffff;\"\u003eSAMO ZA ISTRAŽIVANJE\u003c\/span\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\u003c!-- STATISTIKA --\u003e\n\u003cdiv style=\"display: grid; grid-template-columns: repeat(3,1fr); border-top: 1px solid #FFFFFF; border-bottom: 1px solid #FFFFFF;\"\u003e\n\u003cdiv style=\"padding: 22px 10px; text-align: center; border-right: 1px solid #FFFFFF;\"\u003e\n\u003cdiv style=\"font-size: 25px; font-weight: 800; color: #ffffff;\"\u003e03\u003c\/div\u003e\n\u003cdiv style=\"font-size: 8px; line-height: 1.4; text-transform: uppercase; color: #f3f3f3; margin-top: 5px;\"\u003eCiljana\u003cbr\u003ereceptora\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"padding: 22px 10px; text-align: center; border-right: 1px solid #FFFFFF;\"\u003e\n\u003cdiv style=\"font-size: 25px; font-weight: 800; color: #ffffff;\"\u003e~6\u003c\/div\u003e\n\u003cdiv style=\"font-size: 8px; line-height: 1.4; text-transform: uppercase; color: #f3f3f3; margin-top: 5px;\"\u003eDana\u003cbr\u003epoluživot\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"padding: 22px 10px; text-align: center;\"\u003e\n\u003cdiv style=\"font-size: 25px; font-weight: 800; color: #ffffff;\"\u003e20 mg\u003c\/div\u003e\n\u003cdiv style=\"font-size: 8px; line-height: 1.4; text-transform: uppercase; color: #f3f3f3; margin-top: 5px;\"\u003eSpecifikacija\u003cbr\u003ebočice\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!-- MOLEKULA --\u003e\n\u003cdiv style=\"padding: 52px 22px; background: #F3F3F3; color: #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 9px; letter-spacing: 2.5px; color: #005cff; text-transform: uppercase; margin-bottom: 12px;\"\u003e01 \/ MOLEKULA\u003c\/div\u003e\n\u003ch2 style=\"font-size: clamp(34px,10vw,58px); line-height: .98; letter-spacing: -2px; margin: 0 0 20px; color: #121212;\"\u003eJedna molekula.\u003cbr\u003e\u003cspan style=\"color: #005cff;\"\u003eTri biološke mete.\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003cp style=\"max-width: 750px; color: #121212; font-size: 14px; line-height: 1.8; margin: 0;\"\u003eRetatrutide, poznat i pod razvojnim nazivom LY3437943, eksperimentalna je molekula dizajnirana za aktivaciju GIP, GLP-1 i glukagonskih receptora. Upravo kombinacija ova tri mehanizma predstavlja ključni predmet znanstvenog interesa.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c!-- MEHANIZAM --\u003e\n\u003cdiv style=\"padding: 45px 18px; background: #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"background: #F3F3F3; border-radius: 20px; padding: 22px; color: #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 9px; letter-spacing: 2.5px; color: #005cff; text-transform: uppercase; margin-bottom: 20px;\"\u003eMEHANIZAM \/ 03 CILJA\u003c\/div\u003e\n\u003cdiv style=\"display: flex; flex-direction: column; gap: 10px;\"\u003e\n\u003cdiv style=\"background: #FFFFFF; border-radius: 15px; padding: 20px; border: 1px solid #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 11px; color: #005cff; letter-spacing: 2px; font-weight: bold;\"\u003e01\u003c\/div\u003e\n\u003ch3 style=\"margin: 10px 0 7px; font-size: 20px; color: #121212;\"\u003eGIP\u003c\/h3\u003e\n\u003cp style=\"font-size: 13px; color: #121212; line-height: 1.65; margin: 0;\"\u003eReceptor uključen u regulaciju metaboličkih procesa i odgovor organizma na unos hrane.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"background: #FFFFFF; border-radius: 15px; padding: 20px; border: 1px solid #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 11px; color: #005cff; letter-spacing: 2px; font-weight: bold;\"\u003e02\u003c\/div\u003e\n\u003ch3 style=\"margin: 10px 0 7px; font-size: 20px; color: #121212;\"\u003eGLP-1\u003c\/h3\u003e\n\u003cp style=\"font-size: 13px; color: #121212; line-height: 1.65; margin: 0;\"\u003eReceptor povezan s regulacijom apetita, glukoze i različitih metaboličkih procesa.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"background: #FFFFFF; border-radius: 15px; padding: 20px; border: 1px solid #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 11px; color: #005cff; letter-spacing: 2px; font-weight: bold;\"\u003e03\u003c\/div\u003e\n\u003ch3 style=\"margin: 10px 0 7px; font-size: 20px; color: #121212;\"\u003eGLUKAGON\u003c\/h3\u003e\n\u003cp style=\"font-size: 13px; color: #121212; line-height: 1.65; margin: 0;\"\u003eReceptor koji se istražuje zbog moguće uloge u regulaciji energije i metabolizma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!-- ISTRAŽIVANJA --\u003e\n\u003cdiv style=\"padding: 52px 22px; background: #FFFFFF; color: #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 9px; letter-spacing: 2.5px; color: #005cff; text-transform: uppercase; margin-bottom: 12px;\"\u003e02 \/ KLINIČKA ISTRAŽIVANJA\u003c\/div\u003e\n\u003ch2 style=\"font-size: clamp(35px,10vw,55px); line-height: .98; letter-spacing: -2px; margin: 0 0 24px; color: #121212;\"\u003ePodaci\u003cbr\u003e\u003cspan style=\"color: #005cff;\"\u003ese razvijaju.\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003cp style=\"color: #121212; font-size: 14px; line-height: 1.8; margin: 0 0 18px;\"\u003eRetatrutide je prošao kroz rane faze kliničkog istraživanja i nastavio razvoj kroz Phase 3 studije. U Phase 2 istraživanju objavljenom u časopisu \u003cem\u003eNew England Journal of Medicine\u003c\/em\u003e, istraživači su pratili učinke različitih doza tijekom 48 tjedana.\u003c\/p\u003e\n\u003cp style=\"color: #121212; font-size: 14px; line-height: 1.8; margin: 0;\"\u003eTijekom 2026. godine objavljeni su i novi rezultati Phase 3 programa. Rezultati kliničkih ispitivanja odnose se na konkretne istraživačke populacije i protokole te ne predstavljaju jamstvo individualnog rezultata.\u003c\/p\u003e\n\u003cdiv style=\"margin-top: 22px; padding: 17px; border-left: 3px solid #005CFF; background: #F3F3F3;\"\u003e\n\u003cdiv style=\"font-size: 12px; color: #121212; font-weight: bold;\"\u003eVAŽNA RAZLIKA\u003c\/div\u003e\n\u003cdiv style=\"font-size: 12px; color: #121212; line-height: 1.6; margin-top: 5px;\"\u003eKlinički rezultati nisu isto što i individualno medicinsko očekivanje.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!-- KLINIČKI PODACI --\u003e\n\u003cdiv style=\"padding: 50px 18px; background: #F3F3F3; color: #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 9px; letter-spacing: 2.5px; color: #005cff; text-transform: uppercase; margin-bottom: 20px;\"\u003eKLINIČKI PODACI\u003c\/div\u003e\n\u003cdiv style=\"display: flex; flex-direction: column; gap: 12px;\"\u003e\n\u003cdiv style=\"padding: 25px; border-radius: 18px; background: #FFFFFF; border: 1px solid #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 42px; font-weight: 800; letter-spacing: -2px; color: #005cff;\"\u003e24,2%\u003c\/div\u003e\n\u003cdiv style=\"font-size: 12px; color: #121212; margin-top: 8px; line-height: 1.6;\"\u003eProsječno smanjenje tjelesne mase nakon 48 tjedana u 12 mg skupini Phase 2 istraživanja.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"padding: 25px; border-radius: 18px; background: #FFFFFF; border: 1px solid #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 42px; font-weight: 800; letter-spacing: -2px; color: #005cff;\"\u003e28,3%\u003c\/div\u003e\n\u003cdiv style=\"font-size: 12px; color: #121212; margin-top: 8px; line-height: 1.6;\"\u003eProsječno smanjenje tjelesne mase nakon 80 tjedana u 12 mg skupini prema Lillyjevim Phase 3 rezultatima za TRIUMPH-1.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"font-size: 9px; color: #121212; margin-top: 13px; line-height: 1.6;\"\u003ePodaci potječu iz različitih kliničkih istraživanja s različitim populacijama, protokolima i vremenskim razdobljima. Brojke nisu međusobno izravno usporedive niti predstavljaju očekivani rezultat pojedinca.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!-- SPECIFIKACIJE --\u003e\n\u003cdiv style=\"padding: 50px 18px; background: #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"border: 1px solid #FFFFFF; border-radius: 20px; overflow: hidden;\"\u003e\n\u003cdiv style=\"padding: 23px; border-bottom: 1px solid #FFFFFF;\"\u003e\n\u003cdiv style=\"font-size: 9px; letter-spacing: 2.5px; color: #005cff; text-transform: uppercase;\"\u003eSPECIFIKACIJA PROIZVODA\u003c\/div\u003e\n\u003ch2 style=\"font-size: 27px; margin: 8px 0 0; color: #ffffff;\"\u003eRETA 20 MG\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"display: flex; flex-direction: column;\"\u003e\n\u003cdiv style=\"padding: 19px 23px; border-bottom: 1px solid #FFFFFF;\"\u003e\n\u003cdiv style=\"font-size: 9px; color: #f3f3f3; text-transform: uppercase; letter-spacing: 1px;\"\u003eSpoj\u003c\/div\u003e\n\u003cdiv style=\"font-size: 14px; margin-top: 6px; color: #ffffff;\"\u003eRetatrutide \/ LY3437943\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"padding: 19px 23px; border-bottom: 1px solid #FFFFFF;\"\u003e\n\u003cdiv style=\"font-size: 9px; color: #f3f3f3; text-transform: uppercase; letter-spacing: 1px;\"\u003eFormat\u003c\/div\u003e\n\u003cdiv style=\"font-size: 14px; margin-top: 6px; color: #ffffff;\"\u003eIstraživačka bočica\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"padding: 19px 23px; border-bottom: 1px solid #FFFFFF;\"\u003e\n\u003cdiv style=\"font-size: 9px; color: #f3f3f3; text-transform: uppercase; letter-spacing: 1px;\"\u003eKategorija\u003c\/div\u003e\n\u003cdiv style=\"font-size: 14px; margin-top: 6px; color: #ffffff;\"\u003eIstraživački peptid\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"padding: 19px 23px;\"\u003e\n\u003cdiv style=\"font-size: 9px; color: #f3f3f3; text-transform: uppercase; letter-spacing: 1px;\"\u003eStatus\u003c\/div\u003e\n\u003cdiv style=\"font-size: 14px; margin-top: 6px; color: #ffffff;\"\u003eEksperimentalni\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!-- FAQ --\u003e\n\u003cdiv style=\"padding: 52px 22px; background: #FFFFFF; color: #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 9px; letter-spacing: 2.5px; color: #005cff; text-transform: uppercase; margin-bottom: 12px;\"\u003eČESTA PITANJA\u003c\/div\u003e\n\u003ch2 style=\"font-size: clamp(35px,10vw,48px); line-height: 1; letter-spacing: -2px; margin: 0 0 28px; color: #121212;\"\u003eIstraživanje.\u003cbr\u003e\u003cspan style=\"color: #005cff;\"\u003eBez nagađanja.\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003cdiv style=\"border-top: 1px solid #121212;\"\u003e\n\u003cdiv style=\"padding: 21px 0; border-bottom: 1px solid #121212;\"\u003e\n\u003cstrong style=\"font-size: 14px;\"\u003eŠto je RETA?\u003c\/strong\u003e\n\u003cp style=\"font-size: 13px; color: #121212; line-height: 1.7; margin: 8px 0 0;\"\u003eRETA je naziv koji se često koristi za retatrutide, poznat i pod razvojnim nazivom LY3437943. Riječ je o eksperimentalnoj molekuli koja aktivira GIP, GLP-1 i glukagonske receptore.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"padding: 21px 0; border-bottom: 1px solid #121212;\"\u003e\n\u003cstrong style=\"font-size: 14px;\"\u003eJe li retatrutide odobren lijek?\u003c\/strong\u003e\n\u003cp style=\"font-size: 13px; color: #121212; line-height: 1.7; margin: 8px 0 0;\"\u003eNe. Retatrutide je i dalje investigacijska molekula i nije odobren za javnu uporabu.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"padding: 21px 0; border-bottom: 1px solid #121212;\"\u003e\n\u003cstrong style=\"font-size: 14px;\"\u003eZašto je predmet znanstvenog interesa?\u003c\/strong\u003e\n\u003cp style=\"font-size: 13px; color: #121212; line-height: 1.7; margin: 8px 0 0;\"\u003eZbog istovremenog djelovanja na tri različita hormonska receptora i rezultata dobivenih kroz klinička istraživanja.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"padding: 21px 0;\"\u003e\n\u003cstrong style=\"font-size: 14px;\"\u003eJe li stranica medicinski savjet?\u003c\/strong\u003e\n\u003cp style=\"font-size: 13px; color: #121212; line-height: 1.7; margin: 8px 0 0;\"\u003eNe. Informacije služe isključivo za edukativne i istraživačke svrhe te ne zamjenjuju savjet kvalificiranog zdravstvenog stručnjaka.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!-- DISCLAIMER --\u003e\n\u003cdiv style=\"padding: 35px 18px; background: #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"border: 1px solid #005CFF; border-radius: 18px; padding: 23px; background: #121212; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 10px; letter-spacing: 2px; color: #005cff; text-transform: uppercase; margin-bottom: 10px;\"\u003eVAŽNA NAPOMENA\u003c\/div\u003e\n\u003cp style=\"font-size: 11px; color: #f3f3f3; line-height: 1.8; margin: 0;\"\u003eRetatrutide je investigacijska molekula koja nije odobrena za javnu uporabu. Ovaj proizvod i informacije na ovoj stranici nisu namijenjeni dijagnosticiranju, liječenju, prevenciji ili ublažavanju bolesti niti predstavljaju medicinski savjet.\u003c\/p\u003e\n\u003cp style=\"font-size: 11px; color: #f3f3f3; line-height: 1.8; margin: 12px 0 0;\"\u003eSadržaj je namijenjen isključivo zakonitim istraživačkim i edukativnim svrhama, gdje je to dopušteno važećim zakonima. Ne predstavljamo niti jamčimo individualne rezultate.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!-- IZVORI --\u003e\n\u003cdiv style=\"padding: 25px 22px 32px; background: #121212; border-top: 1px solid #FFFFFF; box-sizing: border-box;\"\u003e\n\u003cdiv style=\"font-size: 8px; letter-spacing: 2px; color: #f3f3f3; text-transform: uppercase; margin-bottom: 10px;\"\u003eZNANSTVENI IZVORI\u003c\/div\u003e\n\u003cdiv style=\"font-size: 9px; color: #f3f3f3; line-height: 1.8;\"\u003eJastreboff AM i sur. \u003cem\u003eTriple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial.\u003c\/em\u003e New England Journal of Medicine, 2023.\u003cbr\u003eEli Lilly and Company — klinička ažuriranja retatrutida, 2026.\u003cbr\u003eEli Lilly — informacije o statusu retatrutida, 2026.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Peptidi Hrvatska","offers":[{"title":"Default Title","offer_id":50448785571907,"sku":null,"price":195.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/0421\/9715\/files\/WhatsApp_Image_2026-09-24_at_02.28.26.jpg?v=1790209996","url":"https:\/\/peptidi-hrvatska.com\/products\/retatrutide-20-mg","provider":"Peptidi Hrvatska","version":"1.0","type":"link"}